Nutriband Inc. (NTRB)
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
Lifecore Biomedical (LFCR)
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
Castle Biosciences Inc (CSTL)
Castle Biosciences to Participate in Upcoming Investor Conferences
IQVIA Holdings Inc. (IQV)
IQVIA Reports Third-Quarter 2025 Results
Bioventus Inc (BVS)
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
Ocular Therapeutix Inc (OCUL)
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
Tenet Healthcare Corporation (THC)
Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook
Merck & Company Inc (MRK)
Merck Announces KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Clear Cell Renal Cell Carcinoma (RCC) Following Nephrectomy
Avidity Biosciences Inc (RNA)
RNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avidity Biosciences, Inc. Is Fair to Shareholders
GeneDx Holdings (WGSWW)
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights